Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | GRIK1 | P39086 | 1/20 | 0.32 |
| ▸ | GRIK2 | Q13002 | 1/20 | 0.32 |
| ▸ | CTSK | P43235 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL18501471 | 1.00 | GRIK1 (0.32) | GRIK1GRIK2CTSK | |
| SCHEMBL18501473 | 1.00 | GRIK1 (0.32) | GRIK1GRIK2CTSK | |
| SCHEMBL9090285 | 0.81 | MEN1 (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL13554185 | 0.81 | GRIK1 (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL9547937 | 0.81 | MEN1 (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL16405374 | 0.81 | GRIK1 (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL14296323 | 0.81 | GRIK1 (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL995538 | 0.77 | CTSK (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL16406945 | 0.77 | CTSK (0.33) | GRIK1GRIK2CTSK | |
| SCHEMBL14243655 | 0.77 | CTSK (0.33) | GRIK1GRIK2CTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-10005753-B2 | Methods for producing beraprost and its derivatives | LUNG BIOTECHNOLOGY PBC (US) | 2018-06-26 | — | — | US | disclosed |
| US-20170166545-A1 | METHODS FOR PRODUCING BERAPROST AND ITS DERIVATIVES | LUNG BIOTECHNOLOGY PBC (US) | 2017-06-15 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (2 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170166545-A1 | METHODS FOR PRODUCING BERAPROST AND ITS DERIVATIVES | CYP51A1, COASY, BLVRB | GRIK1 2608/4885GRIK2 2680/4885CTSK 1310/4885 |
| US-10005753-B2 | Methods for producing beraprost and its derivatives | CYP51A1, COASY, BLVRB | GRIK1 2608/4885GRIK2 2680/4885CTSK 1310/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.